Biotech6 months ago
Neuraxpharm Anticipates 13% Growth in 2024 and a Boost to Production in Spain
Neuraxpharm aims for €500 million in net sales in 2024, up 13.6% from €440 million last year, driven by its focus on CNS disorder treatments. Acquisitions,...